Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CACNA1C | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | WNK3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | GALNT11 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | NR2C2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | CDC14B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | CPN1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | B2M | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | KRIT1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | TIMM10 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | CTSD | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |